1. Home
  2. WVE vs SXI Comparison

WVE vs SXI Comparison

Compare WVE & SXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$13.35

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Logo Standex International Corporation

SXI

Standex International Corporation

N/A

Current Price

$258.21

Market Cap

2.7B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
SXI
Founded
2012
1955
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.7B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
WVE
SXI
Price
$13.35
$258.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
3
Target Price
$31.47
$281.33
AVG Volume (30 Days)
2.2M
132.9K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
0.52%
EPS Growth
N/A
N/A
EPS
N/A
1.42
Revenue
$3,704,000.00
$604,535,000.00
Revenue This Year
N/A
$15.98
Revenue Next Year
$119.93
$8.09
P/E Ratio
N/A
$184.70
Revenue Growth
149.43
N/A
52 Week Low
$5.28
$128.85
52 Week High
$21.73
$270.87

Technical Indicators

Market Signals
Indicator
WVE
SXI
Relative Strength Index (RSI) 47.54 53.19
Support Level $12.53 $216.40
Resistance Level $14.56 $266.94
Average True Range (ATR) 0.79 10.73
MACD 0.01 -0.30
Stochastic Oscillator 23.84 64.91

Price Performance

Historical Comparison
WVE
SXI

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About SXI Standex International Corporation

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. The company has five reportable segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The maximum revenue is generated from its Electronics segment, which is a component and value-added services provider of both sensing and switching technologies, as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging, among others. Geographically, it derives key revenue from the United States and the rest from the Asia Pacific, Europe, the Middle East, and Africa (EMEA), as well as other regions.

Share on Social Networks: